title: Increased isoprostane content in coronary plaques obtained from vulnerable patients.
abstract: 8-Iso-prostaglandin F(2)(alpha) (8-iso-PGF(2)(alpha)), a representative isoprostane, is a reliable biomarker for enhanced oxidant stress in vivo. Its urinary excretion has been proposed as a risk marker in patients with coronary heart disease. Isoprostane content has not yet been well elucidated so far in human coronary plaques. The aim of this study was to evaluate content of immunoreactive 8-iso-PGF(2)(alpha) in directional coronary atherectomy (DCA) specimens from patients with coronary heart diseases. Twenty-seven patients with stable angina pectoris (SAP) and 8 vulnerable patients (5 patients with unstable angina pectoris and 3 with recent myocardial infarction) were subjected to DCA. The specimens from SAP consisted of 14 de novo and 13 restenotic lesions, whereas those from the vulnerable patients were all de novo lesions. Total 8-iso-PGF(2)(alpha) content in the DCA specimens from the vulnerable patients was significantly greater than that from patients with SAP (5.48 (2.70-10.43) versus 2.38 (1.19-4.32)ng/g tissue, median (interquartile range), P<0.05). There was no significant difference in total 8-iso-PGF(2)(alpha) content between de novo and restenotic lesions from patients with SAP (3.25 (1.48-5.05) versus 1.57 (0.62-2.47)ng/g tissue, respectively, P=0.895). Total 8-iso-PGF(2)(alpha) content in apparently normal peripheral artery specimens was only 0.34 (0.26-0.46)ng/g tissue. In conclusion, 8-iso-PGF(2)(alpha) was enriched in the DCA specimens from vulnerable patients, suggesting a crucial role of free radicals in formation of vulnerable plaques and a putative benefit of anti-oxidant therapy on these patients.
authors.affiliation: Department of Cardiology, Higashi-osaka City General Hospital, Osaka, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Nishibe
authors.forename: Y
authors.initials: Y
authors.lastname: Kijima
authors.forename: M
authors.initials: M
authors.lastname: Fukunaga
authors.forename: N
authors.initials: N
authors.lastname: Nishiwaki
authors.forename: T
authors.initials: T
authors.lastname: Sakai
authors.forename: Y
authors.initials: Y
authors.lastname: Nakagawa
authors.forename: T
authors.initials: T
authors.lastname: Hata
mesh_terms: D000208:Acute Disease; D000368:Aged; D000787:Angina Pectoris / Q000097:blood* / Q000601:surgery / Q000652:urine; D017225:Atherectomy, Coronary; D003327:Coronary Disease / Q000097:blood* / Q000601:surgery; D015237:Dinoprost / Q000031:analogs & derivatives / Q000097:blood; D005260:Female; D006801:Humans; D028421:Isoprostanes / Q000097:blood* / Q000652:urine; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000097:blood
chemical_list: D028421:Isoprostanes; C075750:8-epi-prostaglandin F2alpha; D015237:Dinoprost